This event has ended.
The event tackled the EIC Accelerator challenge ‘Novel biomarker-based assays to guide personalised cancer treatment’, targeting SMEs and start-ups that want to scale up their innovations. During the Q&A session, participants had the opportunity to interact with Programme Manager for Health & Biotechnology Iordanis Arzimanoglou.
For your information, the sessions will not provide information that has been provided at the General Info Day, for instance on how to submit proposals. For participants seeking this type of information, please watch the recording of the General Info day.
Files
PPT - EIC Accelerator Challenge: Novel biomarkers-guided cancer treatment
English
- innovation
- Friday 3 February 2023, 09:30 - 12:00 (CET)
- Online only
Programme
- 3 Feb 2023, 09:30 - 21:50 (CET)Welcome & Introduction
Anne-Marie Sassen
(EIC/EISMEA)
- 09:50 - 10:20 (CET)Presentation of the challenge 'Novel biomarker-based assays to guide personalized cancer treatment'
Iordanis Arzimanoglou
(EIC/EISMEA)
- 10:20 - 10:25 (CET)View on the EIC call
Elisabete Weiderpass, IARC Director
- 10:25 - 10:30 (CET)5' Break
- 10:30 - 11:15 (CET)Q&A
Vilma RADVILAITE
(EIC/EISMEA)
- 11:15 - 11:20 (CET)Closing remarks
Iordanis Arzimanoglou
(EIC/EISMEA)
Speakers
Practical information
- When
- Friday 3 February 2023, 09:30 - 12:00 (CET)
- Where
- Online only
- Languages
- English